Skip to main content
. 2021 Dec 2;4(4):1028–1046. doi: 10.20517/cdr.2021.93

Figure 2.

Figure 2

Therapies targeting protein control pathways in multiple myeloma (MM). MM cells are highly dependent on a strictly regulated network of protein quality control pathways such as (A) the ubiquitin-proteasome system (UPS), (B) aggresome formation, (C) autophagy, (D) unfolded protein response, and (E) the heat shock response. Drugs that target these pathways are listed here: FDA-approved drugs (in red) and experimental drugs (in blue).